Literature DB >> 16484354

Pulmonary arteriovenous malformations treated with embolotherapy: helical CT evaluation of long-term effectiveness after 2-21-year follow-up.

Martine Remy-Jardin1, Philippe Dumont, Pierre-Yves Brillet, Philippe Dupuis, Alain Duhamel, Jacques Remy.   

Abstract

PURPOSE: To retrospectively evaluate the long-term results of transcatheter embolotherapy of pulmonary arteriovenous malformations (PAVMs) with helical computed tomography (CT).
MATERIALS AND METHODS: Neither institutional review board approval nor patient consent was required for this retrospective study. Thirty-eight patients underwent follow-up helical chest CT 2-21 years after successful embolotherapy of 64 PAVMs. Four outcome categories were analyzed on the basis of the PAVM morphologic changes and perfusion findings seen on CT angiograms: successful treatment (marked reduction or disappearance of the aneurysmal sac), partially successful treatment (reduced size of the aneurysmal sac and pulmonary vessels, with feeding artery[ies] less than 3 mm in diameter, deemed too small to be occluded), partially failed treatment (reduced size of the aneurysmal sac and pulmonary vessels, with feeding artery[ies] larger than 3 mm and additional embolotherapy required), and failed treatment (similar size of or interim growth in the aneurysmal sac, with unchanged or enlarged pulmonary vessels). chi(2) or Fisher exact tests were used to analyze categorical variables; Mann-Whitney rank tests were used to analyze continuous variables. P < .05 was considered to indicate statistical significance.
RESULTS: Long-term follow-up of the 64 occluded PAVMs revealed successful treatment of 30 (47%), partially successful treatment of 18 (28%), partially failed treatment of two (3%), and failed treatment of 14 (22%) PAVMs. The overall treatment success rate was 75% (47% plus 28%). Delayed recanalization requiring repeat embolotherapy occurred in 12 (19%) cases. No relationship between failed treatment and number of coils deposited in the feeding arteries was found. The frequency of gastrointestinal tract and/or hepatic arteriovenous fistulas at initial diagnosis (P = .01) and/or the interim development of pulmonary hypertension with or without heart failure (P = .01) was significantly higher in patients with at least one PAVM for which embolotherapy failed (n = 9) than in patients who underwent successful or partially successful embolotherapy of all PAVMs (n = 29).
CONCLUSION: Long-term CT follow-up of initially successfully treated PAVMs revealed successful embolotherapy of 75% and partially or completely failed embolotherapy of 25% of PAVMs. (c) RSNA, 2006.

Entities:  

Mesh:

Year:  2006        PMID: 16484354     DOI: 10.1148/radiol.2391050333

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  35 in total

1.  Embolization of pulmonary arteriovenous malformations using the Amplatzer vascular plug: successful treatment of 69 consecutive patients.

Authors:  Jonathan L Hart; Zaid Aldin; Philip Braude; Claire L Shovlin; James Jackson
Journal:  Eur Radiol       Date:  2010-06-24       Impact factor: 5.315

2.  Pulmonary nodular opacities in children with hereditary hemorrhagic telangiectasia.

Authors:  David Manson; Jeffrey Traubici; Meir Mei-Zahav; Ian MacLuskey; Philip John; Derek Stephens
Journal:  Pediatr Radiol       Date:  2007-01-05

Review 3.  Pulmonary arteriovenous malformations: what the interventional radiologist needs to know.

Authors:  Andrea Contegiacomo; Annemilia Del Ciello; Rossella Rella; Nico Attempati; Davide Coppolino; Anna Rita Larici; Carmine Di Stasi; Giuseppe Marano; Riccardo Manfredi
Journal:  Radiol Med       Date:  2019-06-17       Impact factor: 3.469

4.  Location of embolization affects patency after coil embolization for pulmonary arteriovenous malformations: importance of time-resolved magnetic resonance angiography for diagnosis of patency.

Authors:  Masashi Shimohira; Hiro Kiyosue; Keigo Osuga; Hideo Gobara; Hiroshi Kondo; Tetsuro Nakazawa; Yusuke Matsui; Kohei Hamamoto; Tomoya Ishiguro; Miyuki Maruno; Koji Sugimoto; Masamichi Koganemaru; Akira Kitagawa; Koichiro Yamakado
Journal:  Eur Radiol       Date:  2021-01-15       Impact factor: 5.315

5.  Does the type and size of Amplatzer vascular plug affect the occlusion time of pulmonary arteriovenous malformations?

Authors:  Ahmed Kamel Abdel Aal; Moustafa Omar Massoud; Dina Mahmoud Elantably
Journal:  Diagn Interv Radiol       Date:  2017 Jan-Feb       Impact factor: 2.630

6.  Association between reperfusion and shrinkage percentage of the aneurysmal sac after embolization of pulmonary arteriovenous malformation: evaluation based on contrast-enhanced thin-section CT images.

Authors:  Satoko Makimoto; Takao Hiraki; Hideo Gobara; Hiroyasu Fujiwara; Toshihiro Iguchi; Yusuke Matsui; Hidefumi Mimura; Susumu Kanazawa
Journal:  Jpn J Radiol       Date:  2014-03-17       Impact factor: 2.374

7.  Persistence of pulmonary arteriovenous malformations after successful embolotherapy with Amplatzer vascular plug: long-term results.

Authors:  Ahmed Kamel Abdel Aal; Rafik Mohamed Ibrahim; Amr Soliman Moustafa; Maysoon Farouk Hamed; Souheil Saddekni
Journal:  Diagn Interv Radiol       Date:  2016 Jul-Aug       Impact factor: 2.630

8.  Pulmonary arteriovenous malformation presenting as a large aneurysm.

Authors:  S Ganesh Kamath; G Vivek; Shirish Borkar; Padmakumar Ramachandran
Journal:  BMJ Case Rep       Date:  2012-10-12

Review 9.  Hereditary haemorrhagic telangiectasia: a cause of preventable morbidity and mortality.

Authors:  A P Brady; M M Murphy; T M O'Connor
Journal:  Ir J Med Sci       Date:  2008-10-16       Impact factor: 1.568

Review 10.  Imaging of hereditary hemorrhagic telangiectasia.

Authors:  Marie-France Carette; Cosmina Nedelcu; Marc Tassart; Jean-Didier Grange; Marie Wislez; Antoine Khalil
Journal:  Cardiovasc Intervent Radiol       Date:  2008-10-30       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.